Introduction: Bladder cancer is a type of cancer that occurs in the cells of the bladder, which is responsible for storing urine. Says Dr. Erik
Dr. Erik Goluboff
Dr. Erik Goluboff earned his B.A. in biology in 1986 from Columbia University, where he graduated Magna Cum Laude. He then went on to Johns Hopkins University and earned his medical degree in 1990. He has been in the practice of Urology ever since, and has held many positions over his career. He was the Director of Urology at New York-Presbyterian Hospital/The Allen Pavilion and was also a Professor of Clinical Urology at Columbia University College of Physicians and Surgeons.
After almost three decades in academic urologic oncology, he moved on to AstraZeneca, where he held the title of Global Clinical Product Lead while assisting in their late stage research and development efforts in bladder cancer.
Today, Dr. Goluboff is a part of the drug development program at Genentech/Roche, where he is the Principal Medical Lead for urologic cancers, which includes the bladder, kidneys, prostate.
Over his years of service, Erik has won many awards, including the Young Investigator Award from the National Kidney Foundation and Teacher of the Year by 3 different residency programs.